Bleakley Financial Group’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.21M Sell
435,533
-8,128
-2% -$38.1K 0.03% 447
2026
Q1
$1.57M Sell
443,661
-23,341
-5% -$95.6K 0.02% 429
2025
Q4
$2.2M Sell
467,002
-17,588
-4% -$78.4K 0.04% 329
2025
Q3
$2.32M Sell
484,590
-93,855
-16% -$370K 0.05% 273
2025
Q2
$1.39M Buy
578,445
+131,510
+29% +$324K 0.04% 342
2025
Q1
$1.17M Buy
446,935
+92,349
+26% +$298K 0.04% 318
2024
Q4
$1.35M Buy
354,586
+187,362
+112% +$1.01M 0.04% 337
2024
Q3
$1.2M Buy
167,224
+16,647
+11% +$118K 0.04% 368
2024
Q2
$1.1M Buy
+150,577
New +$1.31M 0.03% 395
2023
Q1
Sell
-11,396
Closed -$79.7K 939
2022
Q4
$79.7K Buy
+11,396
New +$117K ﹤0.01% 828

Other funds holding MSOS

Bleakley Financial Group's MSOS Position: Q2 2026 in Review

Bleakley Financial Group reduced its AdvisorShares Pure US Cannabis ETF (MSOS) stake by 1.8% in Q2 2026, selling an estimated $38.1K and leaving 435,533 shares worth $2.21M. The position accounts for 0.03% of the portfolio, ranked #447.

Bleakley Financial Group first reported a position in MSOS in Q4 2022 and has held it in 10 quarters since. The position peaked at $2.32M in Q3 2025. 169 funds tracked by Wall St. Rank hold MSOS as of Q2 2026.

  • Bleakley Financial Group held 435,533 shares of AdvisorShares Pure US Cannabis ETF worth $2.21M as of Q2 2026.
  • Bleakley Financial Group sold 8,128 AdvisorShares Pure US Cannabis ETF shares in Q2 2026, an estimated $38.1K.
  • AdvisorShares Pure US Cannabis ETF made up 0.03% of Bleakley Financial Group's portfolio in Q2 2026, its #447 holding.
  • Bleakley Financial Group first reported a position in AdvisorShares Pure US Cannabis ETF in Q4 2022 and has held it in 10 quarters since.
  • Bleakley Financial Group's AdvisorShares Pure US Cannabis ETF position peaked at $2.32M in Q3 2025.
  • 169 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q2 2026.

Based on Bleakley Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.